|
2024
|
Invention
|
Prime editing of the -115 region in the hbg1 and/or hbg2 promoter for increasing fetal hemoglobin... |
|
|
Invention
|
Hbg2 promoter for increasing fetal hemoglobin content in a eukaryotic cell. HBG1/2 HBG1/2 promote... |
|
|
Invention
|
Anti-neurotensin long fragment and anti-neuromedin n long fragment antibodies and uses thereof. T... |
|
|
Invention
|
Large extracellular vesicles as biomarkers for predicting organ failures and survival time of pat... |
|
|
Invention
|
Nlrp3 inhibitors, pak1/2 inhibitors and/or caspase 1 inhibitors for use in the treatment of rac2 ... |
|
|
Invention
|
Methods for assessing risk of developing a viral disease using a genetic test.
This document pro... |
|
|
Invention
|
Biallelic gene mutations for the diagnosis of neonatal systemic hypertension. The present inventi... |
|
|
Invention
|
Methods and systems for improving anti-cancer therapies. The present disclosure provides improved... |
|
|
Invention
|
Chemically-modified microorganism containing a superoxide dismutase mimic inorganic complex and u... |
|
|
Invention
|
Method for discriminating mono-immunotherapy from combined immunotherapy in cancers. Combination ... |
|
|
Invention
|
Infigratinib for treatment of fgfr3-related skeletal diseases during pregnancy.
FGFR3 gain-of-fu... |
|
|
Invention
|
Methods and pharmaceutical composition for the treatment of sanfilippo syndrome type iiib. The pr... |
|
|
Invention
|
Methods for inhibiting diazepam binding protein.
Autophagy is typically activated by starvation,... |
|
|
Invention
|
Use of hif-1α stabilizing agents for the treatment of type i interferonopathies. Type I interfero... |
|
|
Invention
|
Enrichment of genetically modified hematopoietic stem cells through multiplex base editing. HBGCD... |
|
|
Invention
|
Anti-tuberculosis vaccine targeting selected mycobacterium tuberculosis protective antigens to de... |
|
|
Invention
|
Use of amphiregulin (areg) in methods of treating vascular hyperpermeability. The disruption of e... |
|
|
Invention
|
Autophagy activators for the treatment of rhabdomyolysis. Severe rhabdomyolysis (RM) syndromes ar... |
|
|
Invention
|
Vasorin as a biomarker and biotarget in nephrology. Aiming to identify factors underlying podocyt... |
|
|
Invention
|
New pharmaceutical methionine formulation. L-Methionine is a known essential and natural amino ac... |
|
|
Invention
|
Use of the recombinant fibrinogen-like domain of angiopoietin-like 4 for treating adverse post-is... |
|
2023
|
Invention
|
Methods for prognosis and monitoring pulmonary hypertension. In the present invention, in Pulmona... |
|
|
Invention
|
Use of il-27 antagonists for the treatment of ebv-driven b lymphoproliferative diseases. Upon EBV... |
|
|
Invention
|
Method for determining the relative age of red blood cells. in vitroin vitro determination of the... |
|
|
Invention
|
New inhibitors of phosphatidylinositol 3-kinase. The present invention relates to the prevention ... |
|
|
Invention
|
Methods and pharmaceutical composition for the treatment of alpha-synucleinopathies. The present ... |
|
|
Invention
|
Cd81 as a biomarker and biotarget in t-cell malignancies. The present study of the regulatory T p... |
|
|
Invention
|
Use of inhibitors of the hippo signalling pathway for the treatment of chronic nephropathies. Chr... |
|
|
Invention
|
Use of alpha-v-integrin (cd51) inhibitors for the treatment of cardiac fibrosis.
Activated cardi... |
|
|
Invention
|
Composition for the treatment of antibody deficiencies. The invention is in the field of therapy ... |
|
|
Invention
|
System for identifying respiratory suffering from faciae imaging on a patient, and method using s... |
|
|
Invention
|
A gene signature for diagnosing stimulator of interferon genes (sting)-associated vasculopathy wi... |
|
2022
|
Invention
|
Method to predict a response to immune checkpoint inhibitors in patient with msi cancer. The pres... |
|
|
Invention
|
Irap inhibitors for use in the treatment of inflammatory diseases.
Upon activation, mast cells r... |
|
|
Invention
|
Use of the population of slamf4+ ccr5+ effector memory cd4+ t cells as a biomarker in rheumatoid ... |
|
|
Invention
|
Use of nanoparticles for the treatment of fistulizing anoperineal lesions.
Anoperineal lesions (... |
|
|
Invention
|
Methods for the treatment of ocular rosacea.
Ocular Rosacea (OR) is a chronic inflammatory and n... |
|
|
Invention
|
Method for constructing a mosaic image, and corresponding device and computer program.
A method ... |
|
|
Invention
|
Method for quantifying ahsp protein and its use for prognosing a haemoglobin-related disorder.
T... |
|
|
Invention
|
Methods for improving relaxation of striated myocytes.
The Inventors developed conditions allowi... |
|
|
Invention
|
Use of b cell depleting agents for the treatment of rheumatic heart disease.
Rheumatic heart dis... |
|
|
Invention
|
Methods and compositions for treating pulmonary alveolar proteinosis related to mars mutations.
... |
|
|
Invention
|
Methods for predicting the risk of lymph node metastasis and/or recurrence of patients suffering ... |
|
|
Invention
|
Trem-1 inhibitors for the treatment of marfan syndrome.
Marfan Syndrome is a pathology responsib... |
|
|
Invention
|
Methods of predicting multisystem inflammatory syndrome (mis-c) with severe myocarditis in subjec... |
|
|
Invention
|
Method to diagnose msi cancer.
A method of diagnosing an MSI cancer in a patient including extra... |
|
2021
|
Invention
|
Chlamydia vaccine based on targeting momp vs4 antigen to antigen presenting cells.
Chlamydiae ar... |
